George P. Studzinski

6.6k total citations
180 papers, 5.4k citations indexed

About

George P. Studzinski is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, George P. Studzinski has authored 180 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Molecular Biology, 46 papers in Oncology and 40 papers in Pathology and Forensic Medicine. Recurrent topics in George P. Studzinski's work include Retinoids in leukemia and cellular processes (47 papers), Vitamin D Research Studies (39 papers) and Cancer-related Molecular Pathways (26 papers). George P. Studzinski is often cited by papers focused on Retinoids in leukemia and cellular processes (47 papers), Vitamin D Research Studies (39 papers) and Cancer-related Molecular Pathways (26 papers). George P. Studzinski collaborates with scholars based in United States, Israel and Poland. George P. Studzinski's co-authors include Xuening Wang, Michael Danilenko, Elżbieta Gocek, Zamir Brelvi, Xuening Wang, Qing Mei Wang, Jennifer B. Jones, Milan R. Uskoković, Jonathan S. Harrison and Rosemary Watt and has published in prestigious journals such as Nature, Science and Journal of Clinical Oncology.

In The Last Decade

George P. Studzinski

180 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George P. Studzinski United States 43 3.5k 1.3k 1.2k 790 595 180 5.4k
Elizabeth Yang United States 18 5.7k 1.7× 579 0.4× 1.6k 1.3× 311 0.4× 774 1.3× 25 7.2k
John M. Mariadason Australia 49 5.3k 1.5× 1.1k 0.9× 2.8k 2.3× 834 1.1× 1.4k 2.4× 139 8.3k
Jennifer Jockel United States 9 5.4k 1.6× 461 0.4× 1.1k 0.9× 279 0.4× 655 1.1× 9 6.5k
Alexandru Almasan United States 45 4.4k 1.3× 502 0.4× 1.9k 1.5× 277 0.4× 1.0k 1.7× 96 6.5k
Ching-Shih Chen United States 46 3.3k 1.0× 391 0.3× 920 0.8× 347 0.4× 652 1.1× 83 5.3k
Andrei L. Gartel United States 39 5.4k 1.6× 695 0.5× 2.3k 1.9× 352 0.4× 1.2k 2.0× 84 6.8k
Reid P. Bissonnette United States 26 3.0k 0.9× 301 0.2× 1.2k 1.0× 517 0.7× 539 0.9× 53 4.7k
Hiroko Oshima Japan 40 4.0k 1.1× 876 0.7× 2.2k 1.8× 1.6k 2.0× 1.7k 2.8× 87 8.2k
Joan Gil Spain 38 2.9k 0.8× 440 0.3× 918 0.8× 174 0.2× 509 0.9× 110 4.9k
Christos Paraskeva United Kingdom 46 4.4k 1.3× 1.6k 1.3× 2.8k 2.3× 1.2k 1.5× 2.3k 3.9× 112 8.5k

Countries citing papers authored by George P. Studzinski

Since Specialization
Citations

This map shows the geographic impact of George P. Studzinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George P. Studzinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George P. Studzinski more than expected).

Fields of papers citing papers by George P. Studzinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George P. Studzinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George P. Studzinski. The network helps show where George P. Studzinski may publish in the future.

Co-authorship network of co-authors of George P. Studzinski

This figure shows the co-authorship network connecting the top 25 collaborators of George P. Studzinski. A scholar is included among the top collaborators of George P. Studzinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George P. Studzinski. George P. Studzinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xianding, et al.. (2018). Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen. The Journal of Steroid Biochemistry and Molecular Biology. 187. 166–173. 9 indexed citations
2.
Wang, Xuening, Jonathan S. Harrison, & George P. Studzinski. (2016). BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents. The Journal of Steroid Biochemistry and Molecular Biology. 173. 139–147. 6 indexed citations
3.
Wang, Xuening, Jonathan S. Harrison, & George P. Studzinski. (2015). Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination. The Journal of Steroid Biochemistry and Molecular Biology. 164. 72–78. 15 indexed citations
4.
Gocek, Elżbieta, Anargyros N. Moulas, & George P. Studzinski. (2014). Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells. Critical Reviews in Clinical Laboratory Sciences. 51(3). 125–137. 71 indexed citations
5.
6.
Thompson, Thelma, Michael Andreeff, George P. Studzinski, & Lyubomir T. Vassilev. (2010). 1,25-Dihydroxyvitamin D3 Enhances the Apoptotic Activity of MDM2 Antagonist Nutlin-3a in Acute Myeloid Leukemia Cells Expressing Wild-type p53. Molecular Cancer Therapeutics. 9(5). 1158–1168. 22 indexed citations
7.
8.
Marcinkowska, Ewa, et al.. (2006). Regulation of C/EBPβ isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Experimental Cell Research. 312(11). 2054–2065. 59 indexed citations
9.
Weyts, F.A.A., Puneet Dhawan, Xiaoyu Zhang, et al.. (2004). Novel Gemini analogs of 1α,25-dihydroxyvitamin D3 with enhanced transcriptional activity. Biochemical Pharmacology. 67(7). 1327–1336. 22 indexed citations
10.
Danilenko, Michael & George P. Studzinski. (2004). Enhancement by other compounds of the anti-cancer activity of vitamin D3 and its analogs. Experimental Cell Research. 298(2). 339–358. 51 indexed citations
11.
Studzinski, George P.. (1999). Apoptosis : a practical approach. Oxford University Press eBooks. 45 indexed citations
12.
Harrison, Lawrence E., Qing Mei Wang, & George P. Studzinski. (1999). 1,25‐dihydroxyvitamin D3‐induced retardation of the G2/M traverse is associated with decreased levels of p34cdc2 in HL60 cells. Journal of Cellular Biochemistry. 75(2). 226–234. 1 indexed citations
13.
Chen, Fei & George P. Studzinski. (1999). Cyclin-Dependent Kinase 5 Activity Enhances Monocytic Phenotype and Cell Cycle Traverse in 1,25-Dihydroxyvitamin D3-Treated HL60 Cells. Experimental Cell Research. 249(2). 422–428. 22 indexed citations
14.
15.
Studzinski, George P., et al.. (1996). Transition to tetraploidy in 1,25-dihydroxyvitamin D3-resistant HL60 cells is preceded by reduced growth factor dependence and constitutive up-regulation of Sp1 and AP-1 transcription factors.. PubMed. 56(23). 5513–21. 24 indexed citations
16.
Xu, Huimin, et al.. (1994). A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D,. Cell Proliferation. 27(1). 37–46. 38 indexed citations
17.
Studzinski, George P., et al.. (1992). Inhibition by 1,25 dihydroxyvitamin D3 of c‐myc down‐regulation and DNA fragmentation in cytosine arabinoside–induced erythroid differentiation of K562 cells. Journal of Cellular Physiology. 151(3). 539–548. 3 indexed citations
18.
Kolla, Sarah, Dan C. Moore, & George P. Studzinski. (1991). Vitamin D Analogs Inhibit Erythroid Differentiation and Induce Monocytic Differentiation of Leukemic Cells with the Same Relative Potency. Experimental Biology and Medicine. 197(2). 214–217. 4 indexed citations
19.
Studzinski, George P., et al.. (1991). Association of c‐myc protein with enzymes of DNA replication in high molecular weight fractions from mammalian cells. Journal of Cellular Physiology. 147(3). 412–419. 10 indexed citations
20.
Studzinski, George P., et al.. (1963). Observations on the Weight of the Human Adrenal Gland and the Effect of Preparations of Corticotropin of Different Purity on the Weight and Morphology of the Human Adrenal Gland. The Journal of Clinical Endocrinology & Metabolism. 23(3). 248–254. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Yang Breakdown of academic impact, for papers by John M. Mariadason Breakdown of academic impact, for papers by Jennifer Jockel Breakdown of academic impact, for papers by Alexandru Almasan Breakdown of academic impact, for papers by Ching-Shih Chen Breakdown of academic impact, for papers by Andrei L. Gartel Breakdown of academic impact, for papers by Reid P. Bissonnette Breakdown of academic impact, for papers by Hiroko Oshima Breakdown of academic impact, for papers by Joan Gil Breakdown of academic impact, for papers by Christos Paraskeva
Rankless by CCL
2026